Aro Biotherapeutics Appoints President And CEO As Board Chair; Appoints Purnanand Sarma As CEO

BenzingaFeb 11 08:33 ET

Positive Week for Immunome, Inc. (NASDAQ:IMNM) Institutional Investors Who Lost 53% Over the Past Year

Simply Wall StFeb 6 07:11 ET

Insider Purchase: President and CEO of $IMNM Buys 150,000 Shares

Quiver QuantitativeFeb 3 21:15 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaJan 30 07:07 ET

Immunome Prices Upsized Offering of About 19.4M Shares at $7.75 Per Share >IMNM

Dow JonesJan 29 23:13 ET

Immunome: Gross Proceeds Expected to Be $150M >IMNM

Dow JonesJan 29 23:13 ET